Corporate money in AI: $515B, 21% of deals, and the price of concentration

There are two ways to read the same market. First: corporate venture capital has never deployed more. The State of Corporate Venture Capital 2026 report, co-authored by First Citizens Innovation Banking and Counterpart Ventures from a survey of nearly 200 of the world's largest and most active CVC funds, counts roughly $515 billion invested in corporate-backed rounds so far in 2026. Second: deal activity is shrinking, falling to a nine-year low by the same report's measure.

These numbers do not contradict each other. They describe the same phenomenon: corporate money is concentrating into a narrow set of companies, mostly in artificial intelligence, in very large and very late rounds. For angel investors, this is not a story about Silicon Valley; it is a story about the shape of the funding funnel their seed cheques must eventually pass through.

Fewer deals, bigger cheques

According to PitchBook's Q3 2026 analyst note, corporate investors now account for a record 87.9% of US AI venture deal value in 2026, even as they participate in a smaller share of deals and the population of active CVCs keeps contracting from its 2021 peak. AI makes up more than 90% of all corporate VC deal value. In effect, almost the entire financial weight of this group is pointed at one sector and a handful of the largest names.

PitchBook-NVCA Venture Monitor data for Q2 2026 shows CVCs and corporates took part in just 21.1% of US venture deals in the first half — a decade low — while accounting for 82.6% of deal value. The First Citizens and Counterpart Ventures report reaches a similar shape globally: 21% of deals include at least one corporate investor, yet those rounds absorb close to three quarters of all venture dollars.

That line captures the essential point: the biggest AI deals are being decided at the C-suite, not inside the venture arm. PitchBook describes exactly this split — corporate development teams acquiring or strategically investing in tech unicorns to advance the parent business, while CVC funds continue doing earlier-stage work for financial returns. These are two different pools of money with two different negotiating logics, and founders should tell them apart before sitting down.

Governance decides the quality of corporate money

The most useful part of the 2026 report is not the deployment figure but the governance finding. According to First Citizens and Counterpart Ventures, CVC funds with a venture-savvy executive sponsor complete 98% more deals and generate twice as many exits as those without. That is the most practical yardstick a founder has for judging a corporate fund: who signs off, and does that person understand the tempo of a financing round.

The wider context: Global Corporate Venturing reports that corporate venturing hit a record high in 2025, with more than 3,000 companies actively investing in startups even as the rest of the venture industry declined. The player count is large, but seriousness varies widely — and only those with clear governance tend to stay through a full cycle.

Liquidity is the real bottleneck

The PitchBook-NVCA Venture Monitor for Q3 2026 puts US venture deal value at $515.8 billion through September, roughly 44% above the full-year record set in 2021, with AI accounting for 82.7% of deal value — the highest annual share in the dataset. Q3 alone reached $98.4 billion across an estimated 5,012 deals. Exits have not kept pace: of the 18 venture-backed companies that listed in the quarter, 12 were in healthcare, and none was the kind of AI listing the market has been waiting for.

• Ask where the money comes from: an independent CVC fund or the parent's balance sheet — the two have different time horizons.
• Identify the executive sponsor and check whether that person has worked with startups before.
• Scrutinise strategic terms: rights of first refusal, first-look rights on a sale, exclusive distribution clauses — these can block later rounds and buyers who compete with the parent.
• Keep the commercial contract separate from the investment contract; a purchase order should not be a condition of funding, or vice versa.
• Limit access to operating data to what an ordinary minority shareholder would receive.

Do Ventures' Vietnam Innovation & Private Capital Report 2026 puts Vietnam's private capital market at $4.5 billion across 149 deals, with venture capital back at $509 million, up 28%, even as deal count fell to 103; the $3–10 million and $50 million-plus segments led the recovery, with stable Series A and Pre-A activity. Set against the global data, the picture for Vietnamese angels is clear: corporate money worldwide is piling into very late rounds, so the real gap in Vietnam sits on the stretch from seed up to $3–10 million — precisely the stretch domestic angels and syndicates can fill.

More concretely: first, keep the cap table clean at the angel round and avoid granting broad rights of first refusal to anyone, because that is the clause that makes a regional corporate fund hesitate at the next round. Second, favour sectors where Vietnamese and regional corporates are genuine buyers — supply chain, logistics, energy, fintech serving banks, software for manufacturing — because a commercial contract with a corporate is the cheapest growth evidence for stepping into the $3–10 million bracket. Third, assume the exit path is regional strategic M&A, not a listing: even in the US, only 18 venture-backed companies went public in Q3 2026 and none was an AI name. Unlike Singapore, where international investors are easier to reach, Vietnamese founders should assume the next round will be priced by a regional strategic investor, and build governance, audit and IP records to that buyer's standard from the seed round onward.